Trending...
- HIRO Ostomy Belt Launch by Richard O'Hamill
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of customers using Illumina NextSeq™ 1000 and NextSeq™ 2000 sequencing systems and the GeoMx® Digital Spatial Profiler. The spatial analysis of whole transcriptomes combined with proteome analytes can now be simplified using this integrated, push-button run planning tool.
The new integrated workflow allows GeoMx users to plan their NextSeq 1000/2000 sequencing runs using software on the GeoMx instrument and is coupled to automated downstream data processing using the DRAGEN™ Bio-IT platform, Illumina's industry-leading platform for secondary data analysis. Upon completion of sequence processing, the spatially-resolved digital counts of RNA or protein are ported directly to the GeoMx system, allowing researchers to interact, visualize and analyze their multiomic data.
"As a company, we strive to create end-to-end spatial solutions that are simpler, faster, and more relevant to today's life science challenges," said John Gerace, Chief Commercial Officer, NanoString. "Working together with Illumina, we are ensuring the increasing volume of data is analyzed promptly and that the workflow between our companies' instruments is streamlined to improve customer experiences."
"Illumina is committed to enabling compatible and streamlined workflows with our partner solutions to ensure our customers can implement the workflows that best answer their research questions," said Joel Fellis, VP of Sequencing Platforms Product Management, Illumina. "NanoString's GeoMx Digital Spatial Profiler is enabling a new frontier in discovery research using whole transcriptome analysis and protein detection with spatial context."
More on Washingtoner
The release of the new integrated workflow complements a suite of previously released spatial genomics workflows from the NanoString and Illumina partnership. This includes the GeoMx NGS Pipeline with DRAGEN as a third-party application accessible on the BaseSpace™ Sequence Hub that enables easy coupling of the pipeline processing downstream from any Illumina sequencing platform. The team also co-developed an integrated local workflow with the release of the NanoString GeoMx NGS Pipeline on DRAGEN for NextSeq 1000/2000 platforms to enable customers whose instruments may not be networked. The full suite of streamlined NGS informatics workflows enables GeoMx customers to choose which one best meets their needs.
About NanoString Technologies, Inc
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString's GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in more than 100 peer-reviewed publications. The CosMx™ Spatial Molecular Imager, with commercial availability expected in 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections. For more information, visit www.nanostring.com.
More on Washingtoner
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our products and the anticipated launch of new products and technology. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include market acceptance of our products; delays or denials of regulatory approvals or clearances for products or applications; the extent and duration of the impact of the COVID-19 pandemic and adverse conditions in the general domestic and global economic markets; the effects of ongoing litigation; the impact of competition; the impact of expanded sales, marketing, product development and clinical activities on operating expenses; delays or other unforeseen problems with respect to manufacturing and product development; as well as the other risks set forth in our filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. NanoString Technologies disclaims any obligation to update these forward-looking statements.
NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
Contacts
Doug Farrell, NanoString
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768
The new integrated workflow allows GeoMx users to plan their NextSeq 1000/2000 sequencing runs using software on the GeoMx instrument and is coupled to automated downstream data processing using the DRAGEN™ Bio-IT platform, Illumina's industry-leading platform for secondary data analysis. Upon completion of sequence processing, the spatially-resolved digital counts of RNA or protein are ported directly to the GeoMx system, allowing researchers to interact, visualize and analyze their multiomic data.
"As a company, we strive to create end-to-end spatial solutions that are simpler, faster, and more relevant to today's life science challenges," said John Gerace, Chief Commercial Officer, NanoString. "Working together with Illumina, we are ensuring the increasing volume of data is analyzed promptly and that the workflow between our companies' instruments is streamlined to improve customer experiences."
"Illumina is committed to enabling compatible and streamlined workflows with our partner solutions to ensure our customers can implement the workflows that best answer their research questions," said Joel Fellis, VP of Sequencing Platforms Product Management, Illumina. "NanoString's GeoMx Digital Spatial Profiler is enabling a new frontier in discovery research using whole transcriptome analysis and protein detection with spatial context."
More on Washingtoner
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Stamp Me Launches Web App Ahead of 15th Anniversary
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
The release of the new integrated workflow complements a suite of previously released spatial genomics workflows from the NanoString and Illumina partnership. This includes the GeoMx NGS Pipeline with DRAGEN as a third-party application accessible on the BaseSpace™ Sequence Hub that enables easy coupling of the pipeline processing downstream from any Illumina sequencing platform. The team also co-developed an integrated local workflow with the release of the NanoString GeoMx NGS Pipeline on DRAGEN for NextSeq 1000/2000 platforms to enable customers whose instruments may not be networked. The full suite of streamlined NGS informatics workflows enables GeoMx customers to choose which one best meets their needs.
About NanoString Technologies, Inc
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides three platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,300 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString's GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in more than 100 peer-reviewed publications. The CosMx™ Spatial Molecular Imager, with commercial availability expected in 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections. For more information, visit www.nanostring.com.
More on Washingtoner
- Spokane City Council Passes Chronic Nuisance Properties Ordinance
- City of Spokane and City Council Announce 2027 Legislative Priorities
- LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Tacoma: Council Member Sandesh Sadalge Focuses Today's District 4 Town Hall on the City's Biennial Budget
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our products and the anticipated launch of new products and technology. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include market acceptance of our products; delays or denials of regulatory approvals or clearances for products or applications; the extent and duration of the impact of the COVID-19 pandemic and adverse conditions in the general domestic and global economic markets; the effects of ongoing litigation; the impact of competition; the impact of expanded sales, marketing, product development and clinical activities on operating expenses; delays or other unforeseen problems with respect to manufacturing and product development; as well as the other risks set forth in our filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. NanoString Technologies disclaims any obligation to update these forward-looking statements.
NanoString, NanoString Technologies, the NanoString logo, CosMx, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
Contacts
Doug Farrell, NanoString
Vice President, Investor Relations & Corporate Communications
dfarrell@nanostring.com
Phone: 206-602-1768
0 Comments
Latest on Washingtoner
- Kindering's 21st Luncheon Raises $220,000+ to Support Children with Disabilities and Their Families
- Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- Spokane: City Details Veterans Day Schedule
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- Washington Nurse Introduces Nightingale Care Hub to Help Families Organize Care
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Flags Lowered for Spokane County Sheriff Deputies
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- ARADIA (Est. 1991) Launches First B2A Partner Program for AI
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Spokane: Drugs and Guns Seized in a Counter Narcotics Investigation